Literature DB >> 35309381

Hepatic and mesenteric fibromuscular dysplasia: an uncommon entity.

Zoé Ciccarese1, David Byl1, Vincent Scavee1.   

Abstract

Dissection of the common hepatic artery is a rare cause of acute abdomen. In this case report, we discuss a 58-year-old woman who presented with severe epigastric and back pain, for which she had an abdominal computed tomography (CT) scan. On CT images, a dissection of the common hepatic artery, extending to its right and left dividing branches and a diffusely pathological aspect of the hepatic and digestive arterial network was noted. A diagnosis of extensive fibromuscular dysplasia (FMD) was suggested. FMD is a non-atherosclerotic, non-inflammatory arterial disease that most commonly involves the renal and extracranial carotid arteries, but almost all arterial beds may be affected. There is a high prevalence of aneurysm and dissection among patients with FMD.
© 2022 Published by Elsevier Inc. on behalf of University of Washington.

Entities:  

Keywords:  Arterial disease; Dissection; Fibromuscular dysplasia; String of beads

Year:  2022        PMID: 35309381      PMCID: PMC8927632          DOI: 10.1016/j.radcr.2022.02.009

Source DB:  PubMed          Journal:  Radiol Case Rep        ISSN: 1930-0433


Case summary

A 58-year-old woman presented to our emergency department with complaints of increasing worsening epigastric and back pain for two days. She also had nausea and vomiting. She denied fever, chills, chest pain, dyspnea, cough, rectal bleeding and mictalgia. Review of systems was otherwise negative. The patient suffered from migraines, arterial hypertension and had history of carotid aneurysm. Physical examination of the patient was performed in the emergency department and revealed an otherwise well-appearing patient. Abdominal examination revealed a supple and depressible abdomen with a diffuse tenderness and an epigastric soreness. Peristalsis was normal. There was no rebound, pulsatile, or palpable mass. Physical examination was otherwise unremarkable. The patient was given an intravenous opioid painkiller for pain control. Laboratory results obtained showed neutrophilic hyperleukocytosis, mild hyperlactatemia, increased fibrinogen and slightly disturbed liver enzymes. The rest of the blood biology was ordinary.

Imaging findings and diagnosis

An abdominopelvic computed tomography (CT) with IV contrast performed at the hospital revealed an aneurysmal dilation of the celiac trunk secondary to juxta-ostial stenosis due to the median arcuate ligament. There was also, just downstream from the emergence of the splenic artery, a dissection of the common hepatic artery, extending to its right and left dividing branches (Fig. 1). There was no objectified arterial occlusion. There was no extension to the gastroduodenal, splenic and left gastric arteries.
Fig. 1

(B) The “string of beads” appearance of intrahepatic branches. (D) Alternating stenosis and dilatation of the pancreaticoduodenal arteries. (F) Dissection of the common hepatic artery with an intimal flap.

(B) The “string of beads” appearance of intrahepatic branches. (D) Alternating stenosis and dilatation of the pancreaticoduodenal arteries. (F) Dissection of the common hepatic artery with an intimal flap. In addition, a diffusely pathological aspect of the hepatic and digestive arterial network was noted: multiple vascular irregularities such as alternating stenotic and dilation segments (Fig. 1, Fig. 2). This aspect suggested systemic vasculopathy. A similar aspect affected the renal arteries (Fig. 3). The dissection appeared partially thrombosed in the proximal part of the inferior mesenteric artery (Fig. 2).
Fig. 2

(A/B) The “string of beads” appearance of intrahepatic branches. (C) Intrahepatic artery dissection. (D) Alternating stenosis and dilatation of the pancreaticoduodenal arteries. (E) Dissection of the inferior mesenteric artery.

Fig. 3

Renal arteries caliber irregularities.

(A/B) The “string of beads” appearance of intrahepatic branches. (C) Intrahepatic artery dissection. (D) Alternating stenosis and dilatation of the pancreaticoduodenal arteries. (E) Dissection of the inferior mesenteric artery. Renal arteries caliber irregularities. A diagnosis of extensive fibromuscular dysplasia was suggested, and the therapeutic options include antiplatelet, anticoagulant and antihypertensive therapy.

Discussion

Fibromuscular dysplasia (FMD) is a non-atherosclerotic, non-inflammatory, systemic disease of small- to medium-sized arteries, that may result in arterial beading, stenosis, occlusion, aneurysm, or dissection. FMD mainly affects the renal and extracranial carotid and vertebral arteries, but nearly all vascular beds may be affected, and multivessel involvement is common. The extracranial carotid, renal, and intracranial arteries were the most common sites of aneurysm when dissection most often occurred in the extracranial carotid, vertebral, renal, and coronary arteries [1], [2], [3], [4]. Although a variety of genetic, mechanical, environmental and hormonal factors have been proposed, the mechanism underlying the pathogenesis of FMD remains poorly understood [1], [2], [3], [4], [5], [6]. Most patients with this condition are women, frequently diagnosed in middle age, and present symptoms, depending on the vessels involved, with hypertension, migraine, or complications as such as RA or cerebrovascular event (transient ischemic attack, dizziness, stroke, subarachnoid hemorrhage, …). The prevalence of FMD is not precisely known because this disease is often clinically silent or discovered incidentally [2,3,6]. In the US registry, mesenteric ischemia was uncommon manifestation of FMD, reported in only 1.8% of patients and the celiac and mesenteric arteries accounted for 6.8% of all arterial dissections and 22.3% of all arterial aneurysms reported [1]. FMD is currently classified by angiography into two subtypes, multifocal and focal. The presentation of multifocal FMD is a typical string-of-beads pattern and is at least 4 × more frequent than focal FMD [7]. By the way, visceral artery FMD includes the celiac axis, hepatic, splenic arteries, and the superior and inferior mesenteric arteries. Patients with visceral FMD are more likely to have aneurysms or dissections compared to those without visceral FMD [5,7,8]. The clinical manifestations of FMD are variable and depend on the distribution of vascular beds involvement, the type and severity of arterial lesions [1]. Specifically, clinical symptoms of mesenteric FMD include postprandial abdominal pain, weight loss, fatigue, incomplete intestinal obstruction, focal or multiple ulcers of the intestinal mucosa, and abdominal distension. It is recommended that every patient with FMD undergo one-time cross-sectional imaging from head to pelvis with computed tomographic angiography or magnetic resonance angiography. The factors that distinguishe atherosclerosis from FMD include older age, traditional cardiovascular risk factors, and lesions affecting mainly the ostium and proximal parts of the arteries involved [1,2,4,5]. As opposed to vasculitis like giant cell, Takayasu arteritis, polyarteritis nodosa, Behcet's disease, defined by marked inflammation, FMD is a non-inflammatory process [1]. Computed tomographic angiography, magnetic resonance angiography and duplex ultrasonography is more commonly used to diagnose and monitor the disease [1,3,6,9]. Arteriography is reserved for cases in which there are diagnosis doubts, to measure the pressure gradient across the stenotic lesion or for endovascular treatment [5,6,8,9]. Treatment of FMD depends upon symptoms as well as the nature and location of arterial lesions, but may include both medical (blood pressure control, antiplatelet agents) and interventional therapies (angioplasty, stents, coils, surgery). In the absence of contraindication, antiplatelet therapy is reasonable for patients with FMD to prevent thrombotic and thromboembolic complications. Smoking cessation should be strongly encouraged for all patients with FMD who continue to smoke [1,5,10]. A regular follow-up imaging should be performed at six months from diagnosis in symptomatic patients and it is also recommended once yearly for asymptomatic patients. Follow-up includes clinical assessment, assessment of renal function (for renal artery FMD), and imaging. At this time, there is insufficient data to recommend specific algorithms for modality and frequency of imaging studies in the follow-up of FMD. The timing of follow-up imaging should be customized to each patient's pattern and severity of disease, including the need for monitoring of aneurysms or dissections or following revascularization, as well as local imaging resources and experience [2,7].

Conclusion

Fibromuscular dysplasia is a non-atherosclerotic, non-inflammatory arterial disease that most commonly involves the renal and extracranial carotid arteries, but almost all arterial beds may be affected. Multifocal stenoses with the 'string-of-beads' appearance are observed at angiography in more than 80% of cases. FMD may be clinically silent but many patients present with hypertension, migraine, stroke, transient ischemic attack, subarachnoid hemorrhage, … There is a high prevalence of aneurysm and dissection among patients with FMD. Treatment of FMD include both medical (blood pressure control, antiplatelet agents) and interventional therapies (angioplasty, stents, coils, surgery). A regular follow-up imaging is recommended.

Patient consent

We confirm that written, informed consent for publication of this case was obtained from the patient. Zoé Ciccarese, David Byl, Vincent Scavée
  10 in total

1.  Fibromuscular dysplasia: state of the science and critical unanswered questions: a scientific statement from the American Heart Association.

Authors:  Jeffrey W Olin; Heather L Gornik; J Michael Bacharach; Jose Biller; Lawrence J Fine; Bruce H Gray; William A Gray; Rishi Gupta; Naomi M Hamburg; Barry T Katzen; Robert A Lookstein; Alan B Lumsden; Jane W Newburger; Tatjana Rundek; C John Sperati; James C Stanley
Journal:  Circulation       Date:  2014-02-18       Impact factor: 29.690

2.  High Prevalence of Multiple Arterial Bed Lesions in Patients With Fibromuscular Dysplasia: The ARCADIA Registry (Assessment of Renal and Cervical Artery Dysplasia).

Authors:  Pierre-François Plouin; Jean-Philippe Baguet; Frédéric Thony; Olivier Ormezzano; Arshid Azarine; François Silhol; Catherine Oppenheim; Béatrice Bouhanick; Louis Boyer; Alexandre Persu; Frank Hammer; Philippe Gosse; Claire Mounier-Vehier; Claire Le Hello; Xavier Jeunemaitre; Michel Azizi; Laurence Amar; Gilles Chatellier; Elie Mousseaux; Emmanuel Touzé
Journal:  Hypertension       Date:  2017-07-17       Impact factor: 10.190

Review 3.  First International Consensus on the diagnosis and management of fibromuscular dysplasia.

Authors:  Heather L Gornik; Alexandre Persu; David Adlam; Lucas S Aparicio; Michel Azizi; Marion Boulanger; Rosa Maria Bruno; Peter de Leeuw; Natalia Fendrikova-Mahlay; James Froehlich; Santhi K Ganesh; Bruce H Gray; Cathlin Jamison; Andrzej Januszewicz; Xavier Jeunemaitre; Daniella Kadian-Dodov; Esther Sh Kim; Jason C Kovacic; Pamela Mace; Alberto Morganti; Aditya Sharma; Andrew M Southerland; Emmanuel Touzé; Patricia van der Niepen; Jiguang Wang; Ido Weinberg; Scott Wilson; Jeffrey W Olin; Pierre-Francois Plouin
Journal:  Vasc Med       Date:  2019-01-16       Impact factor: 3.239

Review 4.  Fibromuscular dysplasia of cervicocephalic arteries: Prevalence of multisite involvement and prognosis.

Authors:  M Pasquini; D Trystram; G Nokam; M-P Gobin-Metteil; C Oppenheim; E Touzé
Journal:  Rev Neurol (Paris)       Date:  2015-04-07       Impact factor: 2.607

Review 5.  Fibromuscular Dysplasia: Contemporary Concepts and Future Directions.

Authors:  Nupoor Narula; Daniella Kadian-Dodov; Jeffrey W Olin
Journal:  Prog Cardiovasc Dis       Date:  2018-03-10       Impact factor: 8.194

Review 6.  Fibromuscular dysplasia: Advances in understanding and management.

Authors:  Ellen K Brinza; Heather L Gornik
Journal:  Cleve Clin J Med       Date:  2016-11       Impact factor: 2.321

7.  Dissection and Aneurysm in Patients With Fibromuscular Dysplasia: Findings From the U.S. Registry for FMD.

Authors:  Daniella Kadian-Dodov; Heather L Gornik; Xiaokui Gu; James Froehlich; J Michael Bacharach; Yung-Wei Chi; Bruce H Gray; Michael R Jaff; Esther S H Kim; Pamela Mace; Aditya Sharma; Eva Kline-Rogers; Christopher White; Jeffrey W Olin
Journal:  J Am Coll Cardiol       Date:  2016-07-12       Impact factor: 24.094

Review 8.  Recent developments in the understanding and management of fibromuscular dysplasia.

Authors:  Sarah C O'Connor; Heather L Gornik
Journal:  J Am Heart Assoc       Date:  2014-12       Impact factor: 5.501

Review 9.  Fibromuscular dysplasia.

Authors:  Pierre-François Plouin; Jérôme Perdu; Agnès La Batide-Alanore; Pierre Boutouyrie; Anne-Paule Gimenez-Roqueplo; Xavier Jeunemaitre
Journal:  Orphanet J Rare Dis       Date:  2007-06-07       Impact factor: 4.123

10.  Endovascular management of an unsual case of spontaneous Retroperitoneal Haemorrhage due to Fibromuscular Dysplasia.

Authors:  Juan David Molina-Nuevo; Lorena López-Martínez; María José Pedrosa-Jiménez; Enrique Juliá-Molla
Journal:  CVIR Endovasc       Date:  2020-09-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.